The Shift Away from Asia-Based Medical Device Manufacturing
Medical device OEMs are under growing pressure to deliver faster time-to-market, more resilient supply chains, lower total landed costs, and consistent regulatory compliance.
For years, Asia was the default choice for high-volume manufacturing. But today, that model is increasingly challenged by long and unpredictable lead times, rising freight and logistics costs, limited visibility across supply chains, geopolitical and trade risk, and slower engineering iteration cycles.
As a result, leading OEMs are actively re-evaluating their sourcing strategies, and nearshoring needle manufacturing in Costa Rica is emerging as a high-performing alternative.
Why Costa Rica Is a Strategic Nearshoring Location for Medical Devices
Costa Rica has become one of the most established MedTech manufacturing hubs in the Americas, particularly within the Coyol Free Trade Zone.
Key advantages include proximity to US and LATAM markets, an established medical device ecosystem, strong regulatory alignment with FDA expectations, a skilled engineering and manufacturing workforce, and Free Trade Zone tax and export benefits.
This combination makes Costa Rica ideal for high-precision, regulated manufacturing such as needles, cannulas, and minimally invasive components.
Arrotek Full-Scale Manufacturing in Costa Rica
Arrotek operates a dedicated full-scale medical device manufacturing facility in Costa Rica, designed specifically for scalable production of precision components.
We support OEMs from early-stage development through to high-volume commercial manufacturing.
Core manufacturing capabilities include precision needle and cannula manufacturing, including hypodermic needles, specialty and custom needles, cannulas and stylets, and complex needle assemblies.
Learn more: https://arrotek.com/needle-cannula-contract-manufacturing/
Scalable Production Model
Our facilities supports prototype and pilot builds, process development and validation (IQ/OQ/PQ), full commercial-scale production, and high-volume long-term supply programmes.
Quality and Regulatory Excellence
Arrotek operates an ISO 13485-certified quality management system, FDA-aligned manufacturing processes, ISO Class 8 cleanroom environment (1,000m²), and full traceability and validation control.
Engineering-Led Manufacturing
Unlike traditional contract manufacturers, Arrotek integrates engineering directly into production.
This includes design for manufacturability, process optimisation, yield improvement, design transfer support, and rapid scale-up from concept to production.
This reduces risk, accelerates validation, and improves commercial outcomes.
Nearshoring vs Asia: What OEMs Are Solving
The decision is no longer just about cost, but about supply chain control and speed to market.
Challenges with Asia-based manufacturing include 6 to 12+ week lead times, complex logistics chains, limited engineering iteration speed, high inventory buffers, and exposure to freight volatility and geopolitical risk.
Advantages of nearshoring to Costa Rica include faster delivery to US and regional markets, reduced inventory holding requirements, real-time engineering collaboration, improved quality oversight, and lower total risk-adjusted cost.
For needle manufacturing and precision medical components, these advantages directly impact device availability, regulatory responsiveness, and commercial success.
Why Needle Manufacturing Is Driving Nearshoring Adoption
Needle-based devices require extremely tight tolerances, high-volume repeatability, strict regulatory compliance, and stable validated production processes.
Even minor disruptions in global supply chains can create significant downstream impact in healthcare delivery.
Nearshoring production to Costa Rica enables OEMs to reduce supply risk, accelerate product iterations, improve manufacturing visibility, strengthen quality assurance, and shorten time-to-market.
Arrotek’s Global Manufacturing Network Advantage
Arrotek provides a fully integrated global model across Ireland for engineering, design, and advanced manufacturing, the United States for metals expertise and customer proximity, and Costa Rica for full-scale high-volume production.
This network allows OEMs to move seamlessly from concept to commercial scale without switching suppliers or supply chains.
Full-Scale Manufacturing Built for Medical Device Scale-Up
Our Costa Rica facility is designed specifically for MedTech manufacturing scale requirements, including a 4,000m² total facility footprint, 2,000m² production space, 1,000m² ISO Class 8 cleanroom, and advanced precision manufacturing systems for needles and cannulas.
This infrastructure enables high-volume, cost-efficient, and regulated production at global scale.
Learn more: https://arrotek.com/full-scale-manufacturing/
Conclusion: Nearshoring Is a Competitive Advantage, Not a Cost Decision
Medical device manufacturers are rapidly moving away from traditional offshore models toward regionalised, resilient manufacturing strategies.
For needle and cannula manufacturing in particular, Costa Rica offers a powerful combination of speed, quality, regulatory alignment, supply chain resilience, and scalable production capability.
Arrotek’s full-scale manufacturing operation in Costa Rica enables OEMs to make this transition seamlessly, reducing risk while accelerating growth.
Talk to Our Manufacturing Team
If you are exploring nearshoring needle manufacturing in Costa Rica, Arrotek can support your transition, reach out to [email protected] for more information.
Full-scale manufacturing: https://arrotek.com/full-scale-manufacturing/
Needle and cannula manufacturing: https://arrotek.com/needle-cannula-contract-manufacturing/
